CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities
Net income	$ 126,867	$ 107,130	$ 71,451
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	110,358	97,914	90,077
Stock-based compensation expense	20,320	18,570	39,333
Deferred income taxes	(10,373)	1,190	2,549
Provision for credit losses	9,158	15,673	6,561
Amortization of discount and fees on debt	1,597	1,573	12,620
Noncash operating lease expense	14,728	19,810	19,567
Other	(1,966)	9,949	9,766
Changes in assets and liabilities:
Accounts receivable	(54,908)	(57,501)	(143,073)
Inventories, prepaid expenses, deposits and other current and long-term assets	(19,389)	4,798	(39,164)
Accounts payable	(11,999)	11	18,930
Accrued liabilities	24,132	7,598	15,899
Accrued compensation and benefits	(15,473)	(7,465)	32,437
Operating lease liability	(12,243)	(20,742)	(21,025)
Deferred revenue and other liabilities	22,341	8,376	18,222
Net cash provided by operating activities	203,150	206,884	134,150
Cash flows from investing activities
Purchase of property and equipment	(4,336)	(9,748)	(3,567)
Capitalized software development costs	(44,973)	(42,191)	(31,264)
Capitalized curriculum development costs	(17,239)	(15,687)	(17,432)
Sale of long-lived assets			223
Sale of other investments	60	5,261
Acquisition of MedCerts, LLC, net of cash acquired			(55,031)
Acquisition of Tech Elevator, Inc., net of cash acquired			(16,107)
Acquisition of assets	(1,409)
Other acquisitions, loans and investments, net of distributions	(1,652)	(3,899)	(1,723)
Proceeds from the maturity of marketable securities	91,879	40,163
Purchases of marketable securities	(140,570)	(84,657)	(40,542)
Net cash used in investing activities	(118,240)	(110,758)	(165,443)
Cash flows from financing activities
Repayments on finance lease obligations	(42,956)	(33,011)	(24,315)
Repayments on credit facility			(100,000)
Issuance of convertible senior notes, net of issuance costs			408,610
Purchases of capped calls in connection with convertible senior notes			(60,354)
Payments of contingent consideration	(7,024)
Payments of deferred purchase consideration		(22,858)
Proceeds from exercise of stock options	20	414	748
Withholding of stock options for tax withholding			(10,885)
Repurchase of restricted stock for income tax withholding	(13,541)	(37,855)	(9,228)
Net cash provided by (used in) financing activities	(63,501)	(93,310)	204,576
Net change in cash, cash equivalents and restricted cash	21,409	2,816	173,283
Cash, cash equivalents and restricted cash, beginning of period	389,398	386,582	213,299
Cash, cash equivalents and restricted cash, end of period	$ 410,807	$ 389,398	$ 386,582